James Melhorn
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Key role of thymic stromal lymphopoietin as a molecular target for biologic treatment of severe asthma.
Journal: Frontiers in allergy
Published: July 22, 2025
Baseline Membrane Thickness in Asthma: Where Type-2 Inflammation Meets Remodeling?
Journal: American journal of respiratory and critical care medicine
Published: June 30, 2025
Fractional exhaled nitric oxide and the response to prednisolone for asthma attacks in patients treated with anti-IL5/5Rα therapy: a prospective observational study.
Journal: The European respiratory journal
Published: March 18, 2025
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial.
Journal: The Lancet. Respiratory medicine
Published: August 06, 2024
Type 2 severe asthma: pathophysiology and treatment with biologics.
Journal: Expert review of respiratory medicine
Published: July 12, 2024
Uncontrolled mild-to-moderate asthma may not be mild or moderate, or even asthma: The benefits of early phenotyping.
Journal: Respirology (Carlton, Vic.)
Published: June 19, 2024
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST).
Journal: JMIR research protocols
Published: March 28, 2023
Take a Deep Breath - Time to Plunge into Inducible Laryngeal Obstruction.
Journal: NEJM evidence
Published: January 01, 2023
Persistence of inflammatory and vascular mediators 5 months after hospitalization with COVID-19 infection.
Journal: Frontiers in medicine
Published: November 08, 2022
Should we apply a treatable traits approach to asthma care?
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: December 09, 2021
Last Updated: 09/26/2026